Changing paradigms in the treatment of hormone-receptor positive advanced breast cancer

Expert Opin Pharmacother. 2016 Jun;17(8):1039-41. doi: 10.1517/14656566.2016.1174213. Epub 2016 Apr 14.

Authors

Roberto Filippi¹, Filippo Montemurro²

Affiliations

¹ a Medical School , University of Turin , Turin , Italy.
² b Investigative Clinical Oncology , Fondazione del Piemonte per l'Oncologia (FPO) Candiolo Cancer Institute (IRCCS) , Candiolo , Italy.

PMID: 27042879
DOI: 10.1517/14656566.2016.1174213

No abstract available

Keywords: Breast cancer; CDK 4/6; endocrine therapy; palbociclib; resistance.